BOISE, Idaho, Feb. 26, 2018 -- Healthwise, a leader in evidence-based health education, technology and services, announced that Elizabeth Beem will assume the position of Chief Financial Officer (CFO). Beem joined Healthwise in 2014 and previously served as Senior Vice President of Finance.
|
|||||
Before joining Healthwise, Elizabeth spent 17 years at Hewlett-Packard, where she held several leadership roles in finance, business planning and analytics, and business operations. Beem previously worked as the assistant controller for Smith Sport Optics and an accounting auditor for Arthur Andersen.
As CFO, Beem will lead Healthwise’s finance, accounting, and treasury operations.
“Elizabeth focuses on the value we provide to our health care provider and health plan clients,” said Healthwise CEO Bob Kyte. “She has a wealth of finance operations knowledge and expertise and will be a tremendous asset to Healthwise in this role.”
Beem commented, “I am delighted to work with the Healthwise leadership team to help build on the company’s opportunities to achieve meaningful long-term results for our clients while staying committed to our mission to help people make better health decisions.”
Beem holds an M.B.A. from Boise State University and has a B.A. in Accountancy from the University of Notre Dame.
About Healthwise
Healthwise is a nonprofit organization with a mission to help people make better health decisions. People have turned to Healthwise information more than 2 billion times to learn how to do more for themselves, ask for the care they need, and say “no” to the care they don’t need. Healthwise partners with hospitals, electronic medical record (EMR) providers, health plans, care management companies, and health websites to provide up-to-date, evidence-based information to the people they serve. www.healthwise.org. 1.800.706.9646.
Media Contact:
Sonja Deines
[email protected] | 208-489-8481
A photo accompanying this announcement is available at
http://www.globenewswire.com/NewsRoom/AttachmentNg/a3e1c457-83bb-4cfe-8531-c655ba8af73b


Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 



